Colorado Springs, CO9 Active Studies

Rheumatoid Arthritis Clinical Trials in Colorado Springs, CO

Find 9 actively recruiting rheumatoid arthritis clinical trials in Colorado Springs, CO. Connect with local research sites and explore new treatment options.

9
Active Trials
9
Sponsors
2,929
Enrolling

Recruiting Rheumatoid Arthritis Studies in Colorado Springs

RecruitingColorado Springs, CONCT07012395

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficac...

645 participants
Spyre Therapeutics, Inc.
View Study Details
RecruitingColorado Springs, CONCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine....

640 participants
Pfizer
View Study Details
RecruitingColorado Springs, CONCT05816382

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-861....

500 participants
Takeda
View Study Details
RecruitingColorado Springs, CONCT06373731

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

The goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular degeneration (AMD). The main questions it aims to answ...

360 participants
Stealth BioTherapeutics Inc.
View Study Details
RecruitingColorado Springs, CONCT06979336

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

The purpose of this study is to evaluate the efficacy of RO7837195 compared with placebo in participants with moderately to severely active ulcerative colitis for whom prior treatment with conventiona...

224 participants
Genentech, Inc.
View Study Details
RecruitingColorado Springs, CONCT04804644

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the...

200 participants
NRG Oncology
View Study Details
RecruitingColorado Springs, CONCT06116890

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD....

180 participants
Kyowa Kirin Co., Ltd.
View Study Details
RecruitingColorado Springs, CONCT05769153

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

The primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in subjects with neovascular age-related macular dege...

140 participants
Alcon Research
View Study Details
RecruitingColorado Springs, CONCT06636656

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Adults between 18 and 80 years of age with ulcerative colitis can participate in this study. This is a study for people for whom previous treatment was not successful or who stopped previous treatment...

40 participants
Boehringer Ingelheim
View Study Details

About Rheumatoid Arthritis Clinical Trials in Colorado Springs

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 9 rheumatoid arthritis clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 2,929 participants. Research is being sponsored by Spyre Therapeutics, Inc., Pfizer, Takeda and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Colorado Springs — FAQ

Are there rheumatoid arthritis clinical trials in Colorado Springs?

Yes, there are 9 rheumatoid arthritis clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 9 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated March 2, 2026 from ClinicalTrials.gov